Latest News
Second Covid wave slows patient recruitment for Destiny Pharma
Clinical-stage biotechnology company Destiny Pharma updated the market on its ‘XF-73’ phase 2b clinical study with 101 patients on Monday, out of the target of 125 now recruited.
Goldman bullish on oil and natural gas prices even if Democrats take White House
Goldman Sachs remains 'bullish' on the outlook for oil and natural gas prices, even in the event of a victory for Democratic party candidate Joe Biden at the next US Presidential election on 3 November.
Botswana Diamonds begins precision ground geophysics programme
Botswana Diamonds has started a precision ground geophysics programme to zero-in on potential kimberlite pipes on the prospective Marsfontein and Thorny River properties, it announced on Monday.
Image Scan rises as it launches new x-ray system
Security and industrial inspection x-ray company Image Scan announced the market launch of the ‘AXIS-CXi’ on Monday, which it described as a cabinet x-ray system for use in mailrooms and a range of other security screening environments.
OptiBiotix products launch into retail in Australia, New Zealand
Life sciences company OptiBiotix Health announced the launch of meal replacement shakes and bars containing its ‘OptiBiome’ proprietary weight management technology under the ‘Optislim’ brand with the Woolworths and Chemist Warehouse retailers, and online, in Australia and New Zealand.
Strategic Minerals upbeat on third quarter progress at Cobre
Strategic Minerals updated the market on its third quarter on Monday, reporting “sustained solid” sales growth in the three months ended 30 September, with a 55% year-on-year rise in sales revenue at the Cobre, New Mexico magnetite operation.
Vast Resources reports progress with Baita Plai financing process
Mining company Vast Resources updated the market on progress on the asset-backed debt financing process linked to its Baita Plai Polymetallic Mine in Romania on Monday.
Sanne rallies on RBC Capital markets upgrade
RBC Capital Markets upgraded alternative asset services firm Sanne to ‘outperform’ from ‘sector perform’ on Monday, lifting the price target to 730p from 600p.
Berenberg hikes target price on Electrocomponents
Analysts at Berenberg hiked their target price on industrial and electronics products distributor Electrocomponents from 575. 0p to 815. 0p on Monday, highlighting the acceleration of some pre-existing trends.
Citi sees contrarian 'opportunity' in UK banks
Analysts at Citi reiterated their 'buy' stance on several of the UK's largest lenders, citing the likely resumption of dividend payments from February 2021 onwards among some of the positives for the group.
Twilio to buy Segment for $3.2bn
San Francisco-based cloud communications company Twilio has agreed to buy customer data start-up Segment for around $3. 2bn in shares.
AstraZeneca advances Covid-19 antibodies with US funding
AstraZeneca announced on Monday that its long-acting antibody (LAAB) combination for Covid-19, AZD7442, would advance into two phase 3 clinical trials in more than 6,000 participants both in and outside the US in the coming weeks.
US pre-open: Stimulus talks remain firmly in focus ahead of the bell
US futures had stocks opening higher ahead of the bell on Monday as stimulus talks remained in focus for yet another session.
Europe midday: Shares stay upbeat on US stimulus; UK wary on Covid curbs
European stocks remained in positive territory at lunchtime on Monday, still driven by US stimulus hopes, although the prospect of tighter coronavirus restrictions in the UK dampened London sentiment.
Amigo shares rally as new boss pledges to turn firm around
Amigo’s chief executive has pledged to turn the ailing loans business around as he looks to move on from a lengthy dispute with founder James Benamor.
Europe open: Shares edge higher on Asia gains, US stimulus hopes
European stocks started the week higher, tracking gains in Asia overnight and still driven by US stimulus hopes, although the prospect of tighter coronavirus restrictions in the UK dampened London sentiment.
London midday: Stocks little changed amid prospect of further restrictions
London stocks were little changed by midday on Monday, with sentiment undermined by the prospect of tighter lockdown restrictions in some parts of England.
Argentex H1 revenues slump on Covid-19 deferrals
Foreign exchange services provider Argentex said on Monday that interim revenues had fallen as the Covid-19 pandemic had weighed on activity among clients.
UK unemployment could hit 3m by Christmas - CEBR
The number of unemployed in the UK could rise to 3m by Christmas as the government’s coronavirus furlough scheme ends this month, a leading think tank warned on Monday.
GVC says new German betting licences to hit profit
Gambling group GVC Holdings said it would take a £40m profits hit after being awarded four licences to operate in Germany.